{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T15:45:13Z","timestamp":1769874313881,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"DOI":"10.7759\/cureus.102666","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:31:41Z","timestamp":1769819501000},"source":"Crossref","is-referenced-by-count":0,"title":["Focal Hepatic Steatosis Mimicking a Hilar Tumor With Rapid Resolution After Glycemic Control: A Case Report"],"prefix":"10.7759","author":[{"given":"Hiroteru","family":"Kamimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azusa","family":"Sone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Miyazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzo","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Komoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Horii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Tsujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohito","family":"Sone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Terai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330110","article-title":"Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis","volume":"72","author":"En Li Cho E","year":"2023","unstructured":"En Li Cho E, Ang CZ, Quek J, et al.. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis. Gut. 2023, 72:2138-48. 10.1136\/gutjnl-2023-330110","journal-title":"Gut"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2006.11.005","article-title":"Imaging of hepatic steatosis and fatty sparing","volume":"61","author":"Karcaaltincaba M","year":"2007","unstructured":"Karcaaltincaba M, Akhan O. Imaging of hepatic steatosis and fatty sparing. Eur J Radiol. 2007, 61:33-43. 10.1016\/j.ejrad.2006.11.005","journal-title":"Eur J Radiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.193.1.8090916","article-title":"Pseudolesion in segment IV of the liver at CT during arterial portography: correlation with aberrant gastric venous drainage","volume":"193","author":"Matsui O","year":"1994","unstructured":"Matsui O, Takahashi S, Kadoya M, Yoshikawa J, Gabata T, Takashima T, Kitagawa K. Pseudolesion in segment IV of the liver at CT during arterial portography: correlation with aberrant gastric venous drainage. Radiology. 1994, 193:31-5. 10.1148\/radiology.193.1.8090916","journal-title":"Radiology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s002709900405","article-title":"Focal fatty infiltration in the posterior aspect of hepatic segment IV associated with aberrant pancreaticoduodenal venous drainage","volume":"22","author":"Fukukura Y","year":"1999","unstructured":"Fukukura Y, Inoue H, Fujiyoshi F, Sasaki M, Ichinari N, Nakajo M. Focal fatty infiltration in the posterior aspect of hepatic segment IV associated with aberrant pancreaticoduodenal venous drainage. Cardiovasc Intervent Radiol. 1999, 22:348-50. 10.1007\/s002709900405","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-6111(00)00021-5","article-title":"Pseudolesion in segment IV of the liver with focal fatty deposition caused by the parabiliary venous drainage","volume":"24","author":"Nakayama T","year":"2000","unstructured":"Nakayama T, Yoshimitsu K, Masuda K. Pseudolesion in segment IV of the liver with focal fatty deposition caused by the parabiliary venous drainage. Comput Med Imaging Graph. 2000, 24:259-63. 10.1016\/S0895-6111(00)00021-5","journal-title":"Comput Med Imaging Graph"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.18.19820","article-title":"Spectrum of pitfalls, pseudolesions, and misdiagnoses in noncirrhotic liver","volume":"211","author":"Elsayes KM","year":"2018","unstructured":"Elsayes KM, Menias CO, Morshid AI, et al.. Spectrum of pitfalls, pseudolesions, and misdiagnoses in noncirrhotic liver. AJR Am J Roentgenol. 2018, 211:97-108. 10.2214\/AJR.18.19820","journal-title":"AJR Am J Roentgenol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i46.7894","article-title":"Hepatic pseudolesions caused by alterations in intrahepatic hemodynamics","volume":"27","author":"Kobayashi S","year":"2021","unstructured":"Kobayashi S. Hepatic pseudolesions caused by alterations in intrahepatic hemodynamics. World J Gastroenterol. 2021, 27:7894-908. 10.3748\/wjg.v27.i46.7894","journal-title":"World J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.17.18136","article-title":"Fat-containing liver lesions on imaging: detection and differential diagnosis","volume":"210","author":"Costa AF","year":"2018","unstructured":"Costa AF, Thipphavong S, Arnason T, Stueck AE, Clarke SE. Fat-containing liver lesions on imaging: detection and differential diagnosis. AJR Am J Roentgenol. 2018, 210:68-77. 10.2214\/AJR.17.18136","journal-title":"AJR Am J Roentgenol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s13244-011-0112-5","article-title":"Fatty liver deposition and sparing: a pictorial review","volume":"2","author":"D\u00e9carie PO","year":"2011","unstructured":"D\u00e9carie PO, Lepanto L, Billiard JS, Olivi\u00e9 D, Murphy-Lavall\u00e9e J, Kauffmann C, Tang A. Fatty liver deposition and sparing: a pictorial review. Insights Imaging. 2011, 2:533-8. 10.1007\/s13244-011-0112-5","journal-title":"Insights Imaging"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018171187","article-title":"Imaging diagnosis of intrahepatic and perihilar cholangiocarcinoma: recent advances and challenges","volume":"288","author":"Joo I","year":"2018","unstructured":"Joo I, Lee JM, Yoon JH. Imaging diagnosis of intrahepatic and perihilar cholangiocarcinoma: recent advances and challenges. Radiology. 2018, 288:7-13. 10.1148\/radiol.2018171187","journal-title":"Radiology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.14.12830","article-title":"Imaging of perihilar cholangiocarcinoma","volume":"204","author":"Engelbrecht MR","year":"2015","unstructured":"Engelbrecht MR, Katz SS, van Gulik TM, Lam\u00e9ris JS, van Delden OM. Imaging of perihilar cholangiocarcinoma. AJR Am J Roentgenol. 2015, 204:782-91. 10.2214\/AJR.14.12830","journal-title":"AJR Am J Roentgenol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016, 64.1388-402. 10.1016\/j.jhep.2015.11.004","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024, 81.492-542. 10.1016\/j.jhep.2024.04.031","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong MJ","year":"2016","unstructured":"Armstrong MJ, Gaunt P, Aithal GP, et al.. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet. 2016, 387:679-90. 10.1016\/S0140-6736(15)00803-X","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome PN","year":"2021","unstructured":"Newsome PN, Buchholtz K, Cusi K, et al.. A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. N Engl J Med. 2021, 384:1113-24. 10.1056\/NEJMoa2028395","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0165","article-title":"Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: a randomized controlled trial (E-LIFT trial)","volume":"41","author":"Kuchay MS","year":"2018","unstructured":"Kuchay MS, Krishan S, Mishra SK, et al.. Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: a randomized controlled trial (E-LIFT trial). Diabetes Care. 2018, 41:1801-8. 10.2337\/dc18-0165","journal-title":"Diabetes Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52603-5","article-title":"Efficacy of sodium glucose cotransporter 2 inhibitors on hepatic fibrosis and steatosis in non-alcoholic fatty liver disease: an updated systematic review and meta-analysis","volume":"14","author":"Ong Lopez AM","year":"2024","unstructured":"Ong Lopez AM, Pajimna JA. Efficacy of sodium glucose cotransporter 2 inhibitors on hepatic fibrosis and steatosis in non-alcoholic fatty liver disease: an updated systematic review and meta-analysis. Sci Rep. 2024, 14:2122. 10.1038\/s41598-024-52603-5","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.04.021","article-title":"Sitagliptin vs. placebo for non-alcoholic fatty liver disease: a randomized controlled trial","volume":"65","author":"Cui J","year":"2016","unstructured":"Cui J, Philo L, Nguyen P, et al.. Sitagliptin vs. placebo for non-alcoholic fatty liver disease: a randomized controlled trial. J Hepatol. 2016, 65:369-76. 10.1016\/j.jhep.2016.04.021","journal-title":"J Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/460853-focal-hepatic-steatosis-mimicking-a-hilar-tumor-with-rapid-resolution-after-glycemic-control-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:31:42Z","timestamp":1769819502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/460853-focal-hepatic-steatosis-mimicking-a-hilar-tumor-with-rapid-resolution-after-glycemic-control-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.102666","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,30]]}}}